The DOI matches its Crossref record.
Small bowel mucosal injury is reduced in healthy subjects treated with celecoxib compared with ibuprofen plus omeprazole, as assessed by video capsule endoscopy
Abstract
SUMMARY: Background Small bowel mucosal injury associated with non‐selective non‐steroidal anti‐inflammatory drugs is being increasingly recognized. Aim To evaluate the incidence of small bowel injury in healthy subjects receiving celecoxib or ibuprofen plus omeprazole using video capsule endoscopy (VCE). Methods Subjects with normal baseline VCE were randomly assigned to receive celecoxib 200 mg b.d., ibuprofen 800 mg t.d.s. plus omeprazole 20 mg o.d. or placebo for 2 weeks. The primary end point was mean number of small bowel mucosal breaks per subject. Secondary end points included correlation of faecal calprotectin levels with the primary outcome. Results After treatment, the mean number of small bowel mucosal breaks per subject and the percentage of subjects with mucosal breaks were 0.7/25.9% for ibuprofen/omeprazole compared with 0.2/6.4% for celecoxib and 0.1/7.1% placebo (both comparisons P < 0.001). There were no significant differences between celecoxib and placebo in any measure. Mean increases in faecal calprotectin levels were higher in subjects receiving ibuprofen/omeprazole compared with celecoxib ( P < 0.001), but no correlation was determined between these levels and small bowel mucosal breaks. Conclusions Among healthy subjects with no baseline endoscopic lesions, celecoxib was associated with significantly fewer small bowel mucosal breaks than ibuprofen/omeprazole as assessed by VCE.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Development of a capsule endoscopy scoring index for small bowel mucosal inflammatory change
GRALNEK, I. M., DEFRANCHIS, R., SEIDMAN, E., LEIGHTON, J. A., LEGNANI, P., & LEWIS, B. S. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03556.x · Cited by 451
Self-citationNonsteroidal anti-inflammatory drugs and upper and lower gastrointestinal mucosal damage
Sostres, C., Gargallo, C. J., & Lanas, A. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4175 · Cited by 406
Chan, F. K., Lanas, A., Scheiman, J., Berger, M. F., Nguyen, H., & Goldstein, J. L. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60673-3 · Cited by 350
Self-citationLanas, Á., Carrera-Lasfuentes, P., Arguedas, Y., García, S., Bujanda, L., Calvet, X., Ponce, J., Perez-Aísa, Á., Castro, M., Muñoz, M., et al. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.11.007 · Cited by 269
Gwee, K.-A., Goh, V., Lima, G., & Setia, S. (2018) · Journal of Pain Research · doi:10.2147/jpr.s156938 · Cited by 117
Metadata
- Authors
- GOLDSTEIN, J. L., EISEN, G. M., LEWIS, B., GRALNEK, I. M., AISENBERG, J., BHADRA, P., & BERGER, M. F.
- Venue
- Alimentary Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2007-03-12
- Volume
- 25
- Issue
- 10
- Pages
- 1211-1222
- ISSN
- 0269-2813 (ISSN-L)
- 1365-2036
- OpenAlex
- W1569709067
- Cited by
- 194
- References
- 0
- FWCI
- 9.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Small bowel mucosal injury is reduced in healthy subjects treated with celecoxib compared with ibuprofen plus omeprazole, as assessed by video capsule endoscopy. https://app.cochat.ai/papers/10.1111/j.1365-2036.2007.03312.x
- The paper
- GOLDSTEIN, J. L., EISEN, G. M., LEWIS, B., GRALNEK, I. M., AISENBERG, J., BHADRA, P., & BERGER, M. F. (2007). Small bowel mucosal injury is reduced in healthy subjects treated with celecoxib compared with ibuprofen plus omeprazole, as assessed by video capsule endoscopy. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/j.1365-2036.2007.03312.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.